.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Johnson and Johnson
Medtronic
US Department of Justice
Fish and Richardson
Boehringer Ingelheim
Federal Trade Commission
Cerilliant
Dow
Queensland Health

Generated: July 22, 2017

DrugPatentWatch Database Preview

CATAFLAM Drug Profile

« Back to Dashboard

What is the patent landscape for Cataflam, and when can generic versions of Cataflam launch?

Cataflam is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in CATAFLAM is diclofenac potassium. There are forty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.

Summary for Tradename: CATAFLAM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list95
Clinical Trials: see list8
Patent Applications: see list1,792
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CATAFLAM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
CATAFLAM
diclofenac potassium
TABLET;ORAL020142-001Nov 24, 1993DISCNYesNo► Subscribe► Subscribe
Novartis
CATAFLAM
diclofenac potassium
TABLET;ORAL020142-002Nov 24, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Harvard Business School
Merck
Chubb
Express Scripts
Fuji
Fish and Richardson
Chinese Patent Office
US Army
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot